nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP2A6—Pilocarpine—glaucoma	0.142	0.218	CbGbCtD
Norfloxacin—SLC22A5—Clonidine—glaucoma	0.091	0.14	CbGbCtD
Norfloxacin—SLC22A6—Methazolamide—glaucoma	0.0717	0.11	CbGbCtD
Norfloxacin—CYP1A1—Clonidine—glaucoma	0.0591	0.0908	CbGbCtD
Norfloxacin—SLC22A6—Acetazolamide—glaucoma	0.0573	0.088	CbGbCtD
Norfloxacin—CYP1A2—Betaxolol—glaucoma	0.0482	0.074	CbGbCtD
Norfloxacin—CYP3A5—Clonidine—glaucoma	0.0355	0.0545	CbGbCtD
Norfloxacin—CYP3A4—Pilocarpine—glaucoma	0.0283	0.0435	CbGbCtD
Norfloxacin—CYP1A2—Clonidine—glaucoma	0.0264	0.0406	CbGbCtD
Norfloxacin—CYP3A4—Brinzolamide—glaucoma	0.0222	0.0341	CbGbCtD
Norfloxacin—CYP3A4—Dorzolamide—glaucoma	0.0215	0.033	CbGbCtD
Norfloxacin—CYP3A4—Methazolamide—glaucoma	0.0191	0.0294	CbGbCtD
Norfloxacin—CYP3A4—Acetazolamide—glaucoma	0.0153	0.0235	CbGbCtD
Norfloxacin—CYP3A4—Clonidine—glaucoma	0.0138	0.0212	CbGbCtD
Norfloxacin—TOP2A—Alprenolol—Metipranolol—glaucoma	0.00162	0.588	CbGdCrCtD
Norfloxacin—TOP2A—Alprenolol—Betaxolol—glaucoma	0.00113	0.412	CbGdCrCtD
Norfloxacin—Dyspepsia—Brimonidine—glaucoma	0.000242	0.000758	CcSEcCtD
Norfloxacin—Hallucination—Betaxolol—glaucoma	0.000241	0.000757	CcSEcCtD
Norfloxacin—Hypoaesthesia—Betaxolol—glaucoma	0.000241	0.000757	CcSEcCtD
Norfloxacin—Hyperhidrosis—Pilocarpine—glaucoma	0.00024	0.000752	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000239	0.00075	CcSEcCtD
Norfloxacin—Tension—Clonidine—glaucoma	0.000238	0.000747	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Travoprost—glaucoma	0.000238	0.000746	CcSEcCtD
Norfloxacin—Insomnia—Dorzolamide—glaucoma	0.000237	0.000744	CcSEcCtD
Norfloxacin—Fatigue—Brimonidine—glaucoma	0.000237	0.000743	CcSEcCtD
Norfloxacin—Anorexia—Pilocarpine—glaucoma	0.000236	0.000741	CcSEcCtD
Norfloxacin—Feeling abnormal—Acetazolamide—glaucoma	0.000236	0.00074	CcSEcCtD
Norfloxacin—Hypersensitivity—Apraclonidine—glaucoma	0.000236	0.000739	CcSEcCtD
Norfloxacin—Nervousness—Clonidine—glaucoma	0.000236	0.000739	CcSEcCtD
Norfloxacin—Paraesthesia—Dorzolamide—glaucoma	0.000236	0.000739	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000235	0.000737	CcSEcCtD
Norfloxacin—Dyspnoea—Dorzolamide—glaucoma	0.000234	0.000734	CcSEcCtD
Norfloxacin—Visual impairment—Betaxolol—glaucoma	0.000234	0.000733	CcSEcCtD
Norfloxacin—Insomnia—Brinzolamide—glaucoma	0.000233	0.000732	CcSEcCtD
Norfloxacin—Somnolence—Dorzolamide—glaucoma	0.000233	0.000731	CcSEcCtD
Norfloxacin—Muscle spasms—Clonidine—glaucoma	0.000233	0.000731	CcSEcCtD
Norfloxacin—Dyspnoea—Travoprost—glaucoma	0.000233	0.00073	CcSEcCtD
Norfloxacin—Paraesthesia—Brinzolamide—glaucoma	0.000232	0.000726	CcSEcCtD
Norfloxacin—Dyspepsia—Dorzolamide—glaucoma	0.000231	0.000724	CcSEcCtD
Norfloxacin—Dyspnoea—Brinzolamide—glaucoma	0.00023	0.000721	CcSEcCtD
Norfloxacin—Dyspepsia—Travoprost—glaucoma	0.00023	0.000721	CcSEcCtD
Norfloxacin—Asthenia—Apraclonidine—glaucoma	0.00023	0.00072	CcSEcCtD
Norfloxacin—Somnolence—Brinzolamide—glaucoma	0.000229	0.000719	CcSEcCtD
Norfloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000229	0.00844	CbGpPWpGaD
Norfloxacin—Vision blurred—Clonidine—glaucoma	0.000229	0.000717	CcSEcCtD
Norfloxacin—Decreased appetite—Dorzolamide—glaucoma	0.000228	0.000715	CcSEcCtD
Norfloxacin—Urticaria—Acetazolamide—glaucoma	0.000227	0.000713	CcSEcCtD
Norfloxacin—Tremor—Clonidine—glaucoma	0.000227	0.000713	CcSEcCtD
Norfloxacin—Dyspepsia—Brinzolamide—glaucoma	0.000227	0.000712	CcSEcCtD
Norfloxacin—Pruritus—Apraclonidine—glaucoma	0.000226	0.00071	CcSEcCtD
Norfloxacin—Body temperature increased—Acetazolamide—glaucoma	0.000226	0.00071	CcSEcCtD
Norfloxacin—Fatigue—Dorzolamide—glaucoma	0.000226	0.000709	CcSEcCtD
Norfloxacin—Tinnitus—Betaxolol—glaucoma	0.000226	0.000709	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000226	0.000708	CcSEcCtD
Norfloxacin—Fatigue—Travoprost—glaucoma	0.000225	0.000706	CcSEcCtD
Norfloxacin—Insomnia—Pilocarpine—glaucoma	0.000224	0.000703	CcSEcCtD
Norfloxacin—Decreased appetite—Brinzolamide—glaucoma	0.000224	0.000703	CcSEcCtD
Norfloxacin—Constipation—Travoprost—glaucoma	0.000223	0.000701	CcSEcCtD
Norfloxacin—Agitation—Clonidine—glaucoma	0.000223	0.000699	CcSEcCtD
Norfloxacin—Paraesthesia—Pilocarpine—glaucoma	0.000223	0.000698	CcSEcCtD
Norfloxacin—Asthenia—Bimatoprost—glaucoma	0.000223	0.000698	CcSEcCtD
Norfloxacin—Fatigue—Brinzolamide—glaucoma	0.000222	0.000697	CcSEcCtD
Norfloxacin—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000222	0.00818	CbGpPWpGaD
Norfloxacin—Angioedema—Clonidine—glaucoma	0.000222	0.000695	CcSEcCtD
Norfloxacin—Dyspnoea—Pilocarpine—glaucoma	0.000221	0.000693	CcSEcCtD
Norfloxacin—Somnolence—Pilocarpine—glaucoma	0.00022	0.000691	CcSEcCtD
Norfloxacin—Pruritus—Bimatoprost—glaucoma	0.00022	0.000688	CcSEcCtD
Norfloxacin—Diarrhoea—Apraclonidine—glaucoma	0.000219	0.000687	CcSEcCtD
Norfloxacin—Dyspepsia—Pilocarpine—glaucoma	0.000218	0.000684	CcSEcCtD
Norfloxacin—Chills—Betaxolol—glaucoma	0.000218	0.000683	CcSEcCtD
Norfloxacin—Feeling abnormal—Dorzolamide—glaucoma	0.000216	0.000678	CcSEcCtD
Norfloxacin—Decreased appetite—Pilocarpine—glaucoma	0.000216	0.000676	CcSEcCtD
Norfloxacin—Feeling abnormal—Travoprost—glaucoma	0.000215	0.000675	CcSEcCtD
Norfloxacin—Conjunctivitis—Timolol—glaucoma	0.000215	0.000673	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000215	0.000673	CcSEcCtD
Norfloxacin—Palpitations—Clonidine—glaucoma	0.000214	0.000672	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Travoprost—glaucoma	0.000214	0.00067	CcSEcCtD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000213	0.00785	CbGpPWpGaD
Norfloxacin—Feeling abnormal—Brinzolamide—glaucoma	0.000213	0.000667	CcSEcCtD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—PEX19—glaucoma	0.000212	0.00783	CbGpPWpGaD
Norfloxacin—Constipation—Pilocarpine—glaucoma	0.000212	0.000665	CcSEcCtD
Norfloxacin—Dizziness—Apraclonidine—glaucoma	0.000212	0.000664	CcSEcCtD
Norfloxacin—Erythema—Betaxolol—glaucoma	0.000211	0.000662	CcSEcCtD
Norfloxacin—Urticaria—Dorzolamide—glaucoma	0.000208	0.000654	CcSEcCtD
Norfloxacin—Abdominal pain—Dorzolamide—glaucoma	0.000207	0.00065	CcSEcCtD
Norfloxacin—Body temperature increased—Dorzolamide—glaucoma	0.000207	0.00065	CcSEcCtD
Norfloxacin—Tension—Betaxolol—glaucoma	0.000207	0.00065	CcSEcCtD
Norfloxacin—Dysgeusia—Betaxolol—glaucoma	0.000207	0.000649	CcSEcCtD
Norfloxacin—Chest pain—Clonidine—glaucoma	0.000207	0.000648	CcSEcCtD
Norfloxacin—Arthralgia—Clonidine—glaucoma	0.000207	0.000648	CcSEcCtD
Norfloxacin—Abdominal pain—Travoprost—glaucoma	0.000207	0.000648	CcSEcCtD
Norfloxacin—CYP1A1—Oxidative Stress—SOD1—glaucoma	0.000206	0.0076	CbGpPWpGaD
Norfloxacin—Agranulocytosis—Timolol—glaucoma	0.000206	0.000646	CcSEcCtD
Norfloxacin—Anxiety—Clonidine—glaucoma	0.000206	0.000645	CcSEcCtD
Norfloxacin—Asthenia—Acetazolamide—glaucoma	0.000205	0.000644	CcSEcCtD
Norfloxacin—Dizziness—Bimatoprost—glaucoma	0.000205	0.000643	CcSEcCtD
Norfloxacin—Nervousness—Betaxolol—glaucoma	0.000205	0.000643	CcSEcCtD
Norfloxacin—Urticaria—Brinzolamide—glaucoma	0.000205	0.000643	CcSEcCtD
Norfloxacin—Feeling abnormal—Pilocarpine—glaucoma	0.000204	0.000641	CcSEcCtD
Norfloxacin—Vomiting—Apraclonidine—glaucoma	0.000203	0.000638	CcSEcCtD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000203	0.00749	CbGpPWpGaD
Norfloxacin—Muscle spasms—Betaxolol—glaucoma	0.000203	0.000637	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000203	0.000636	CcSEcCtD
Norfloxacin—Hypersensitivity—Brimonidine—glaucoma	0.000202	0.000635	CcSEcCtD
Norfloxacin—Dry mouth—Clonidine—glaucoma	0.000202	0.000633	CcSEcCtD
Norfloxacin—Dermatitis—Apraclonidine—glaucoma	0.000202	0.000632	CcSEcCtD
Norfloxacin—Headache—Apraclonidine—glaucoma	0.0002	0.000629	CcSEcCtD
Norfloxacin—Confusional state—Clonidine—glaucoma	0.0002	0.000626	CcSEcCtD
Norfloxacin—Vision blurred—Betaxolol—glaucoma	0.000199	0.000624	CcSEcCtD
Norfloxacin—Oedema—Clonidine—glaucoma	0.000198	0.000621	CcSEcCtD
Norfloxacin—Tremor—Betaxolol—glaucoma	0.000198	0.000621	CcSEcCtD
Norfloxacin—Hallucination—Timolol—glaucoma	0.000197	0.000618	CcSEcCtD
Norfloxacin—Asthenia—Brimonidine—glaucoma	0.000197	0.000618	CcSEcCtD
Norfloxacin—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000196	0.00723	CbGpPWpGaD
Norfloxacin—Abdominal pain—Pilocarpine—glaucoma	0.000196	0.000615	CcSEcCtD
Norfloxacin—Body temperature increased—Pilocarpine—glaucoma	0.000196	0.000615	CcSEcCtD
Norfloxacin—Diarrhoea—Acetazolamide—glaucoma	0.000196	0.000614	CcSEcCtD
Norfloxacin—Rash—Bimatoprost—glaucoma	0.000196	0.000613	CcSEcCtD
Norfloxacin—Dermatitis—Bimatoprost—glaucoma	0.000195	0.000613	CcSEcCtD
Norfloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000195	0.00717	CbGpPWpGaD
Norfloxacin—Pruritus—Brimonidine—glaucoma	0.000194	0.00061	CcSEcCtD
Norfloxacin—Headache—Bimatoprost—glaucoma	0.000194	0.00061	CcSEcCtD
Norfloxacin—Thrombocytopenia—Clonidine—glaucoma	0.000194	0.000608	CcSEcCtD
Norfloxacin—Hypersensitivity—Dorzolamide—glaucoma	0.000193	0.000606	CcSEcCtD
Norfloxacin—Hypersensitivity—Travoprost—glaucoma	0.000192	0.000604	CcSEcCtD
Norfloxacin—CYP1A1—Melatonin metabolism and effects—EDN1—glaucoma	0.000192	0.00709	CbGpPWpGaD
Norfloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000192	0.00708	CbGpPWpGaD
Norfloxacin—Hyperhidrosis—Clonidine—glaucoma	0.000191	0.0006	CcSEcCtD
Norfloxacin—Visual impairment—Timolol—glaucoma	0.000191	0.000599	CcSEcCtD
Norfloxacin—Nausea—Apraclonidine—glaucoma	0.00019	0.000596	CcSEcCtD
Norfloxacin—Hypersensitivity—Brinzolamide—glaucoma	0.00019	0.000596	CcSEcCtD
Norfloxacin—Vertigo—Betaxolol—glaucoma	0.00019	0.000595	CcSEcCtD
Norfloxacin—Dizziness—Acetazolamide—glaucoma	0.000189	0.000594	CcSEcCtD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—glaucoma	0.000189	0.00696	CbGpPWpGaD
Norfloxacin—Anorexia—Clonidine—glaucoma	0.000189	0.000592	CcSEcCtD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000188	0.00694	CbGpPWpGaD
Norfloxacin—Asthenia—Dorzolamide—glaucoma	0.000188	0.00059	CcSEcCtD
Norfloxacin—Asthenia—Travoprost—glaucoma	0.000187	0.000588	CcSEcCtD
Norfloxacin—Palpitations—Betaxolol—glaucoma	0.000187	0.000585	CcSEcCtD
Norfloxacin—Pruritus—Dorzolamide—glaucoma	0.000186	0.000582	CcSEcCtD
Norfloxacin—Asthenia—Brinzolamide—glaucoma	0.000185	0.00058	CcSEcCtD
Norfloxacin—Pruritus—Travoprost—glaucoma	0.000185	0.00058	CcSEcCtD
Norfloxacin—Tinnitus—Timolol—glaucoma	0.000185	0.00058	CcSEcCtD
Norfloxacin—Nausea—Bimatoprost—glaucoma	0.000184	0.000578	CcSEcCtD
Norfloxacin—Hypersensitivity—Pilocarpine—glaucoma	0.000183	0.000573	CcSEcCtD
Norfloxacin—Pruritus—Brinzolamide—glaucoma	0.000182	0.000572	CcSEcCtD
Norfloxacin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000182	0.00672	CbGpPWpGaD
Norfloxacin—Vomiting—Acetazolamide—glaucoma	0.000182	0.000571	CcSEcCtD
Norfloxacin—Dizziness—Brimonidine—glaucoma	0.000182	0.00057	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Clonidine—glaucoma	0.00018	0.000566	CcSEcCtD
Norfloxacin—Chest pain—Betaxolol—glaucoma	0.00018	0.000564	CcSEcCtD
Norfloxacin—Myalgia—Betaxolol—glaucoma	0.00018	0.000564	CcSEcCtD
Norfloxacin—Arthralgia—Betaxolol—glaucoma	0.00018	0.000564	CcSEcCtD
Norfloxacin—Diarrhoea—Dorzolamide—glaucoma	0.00018	0.000563	CcSEcCtD
Norfloxacin—Headache—Acetazolamide—glaucoma	0.000179	0.000562	CcSEcCtD
Norfloxacin—Anxiety—Betaxolol—glaucoma	0.000179	0.000562	CcSEcCtD
Norfloxacin—Insomnia—Clonidine—glaucoma	0.000179	0.000562	CcSEcCtD
Norfloxacin—Diarrhoea—Travoprost—glaucoma	0.000179	0.000561	CcSEcCtD
Norfloxacin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000178	0.00657	CbGpPWpGaD
Norfloxacin—Asthenia—Pilocarpine—glaucoma	0.000178	0.000558	CcSEcCtD
Norfloxacin—Paraesthesia—Clonidine—glaucoma	0.000178	0.000558	CcSEcCtD
Norfloxacin—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000177	0.00654	CbGpPWpGaD
Norfloxacin—Dyspnoea—Clonidine—glaucoma	0.000177	0.000554	CcSEcCtD
Norfloxacin—Diarrhoea—Brinzolamide—glaucoma	0.000176	0.000553	CcSEcCtD
Norfloxacin—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000176	0.00649	CbGpPWpGaD
Norfloxacin—Somnolence—Clonidine—glaucoma	0.000176	0.000552	CcSEcCtD
Norfloxacin—Dry mouth—Betaxolol—glaucoma	0.000176	0.000551	CcSEcCtD
Norfloxacin—Pruritus—Pilocarpine—glaucoma	0.000175	0.00055	CcSEcCtD
Norfloxacin—Confusional state—Betaxolol—glaucoma	0.000174	0.000545	CcSEcCtD
Norfloxacin—Dizziness—Dorzolamide—glaucoma	0.000173	0.000544	CcSEcCtD
Norfloxacin—Rash—Brimonidine—glaucoma	0.000173	0.000543	CcSEcCtD
Norfloxacin—Dermatitis—Brimonidine—glaucoma	0.000173	0.000543	CcSEcCtD
Norfloxacin—Dizziness—Travoprost—glaucoma	0.000173	0.000542	CcSEcCtD
Norfloxacin—CYP2A6—NRF2 pathway—SLC6A13—glaucoma	0.000173	0.00636	CbGpPWpGaD
Norfloxacin—Erythema—Timolol—glaucoma	0.000173	0.000541	CcSEcCtD
Norfloxacin—Oedema—Betaxolol—glaucoma	0.000172	0.000541	CcSEcCtD
Norfloxacin—Headache—Brimonidine—glaucoma	0.000172	0.00054	CcSEcCtD
Norfloxacin—Decreased appetite—Clonidine—glaucoma	0.000172	0.00054	CcSEcCtD
Norfloxacin—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000171	0.00631	CbGpPWpGaD
Norfloxacin—Fatigue—Clonidine—glaucoma	0.000171	0.000535	CcSEcCtD
Norfloxacin—Dizziness—Brinzolamide—glaucoma	0.000171	0.000535	CcSEcCtD
Norfloxacin—Nausea—Acetazolamide—glaucoma	0.00017	0.000533	CcSEcCtD
Norfloxacin—Diarrhoea—Pilocarpine—glaucoma	0.00017	0.000532	CcSEcCtD
Norfloxacin—Tension—Timolol—glaucoma	0.000169	0.000531	CcSEcCtD
Norfloxacin—Constipation—Clonidine—glaucoma	0.000169	0.000531	CcSEcCtD
Norfloxacin—Dysgeusia—Timolol—glaucoma	0.000169	0.00053	CcSEcCtD
Norfloxacin—Thrombocytopenia—Betaxolol—glaucoma	0.000169	0.000529	CcSEcCtD
Norfloxacin—Nervousness—Timolol—glaucoma	0.000168	0.000526	CcSEcCtD
Norfloxacin—Vomiting—Dorzolamide—glaucoma	0.000167	0.000523	CcSEcCtD
Norfloxacin—Hyperhidrosis—Betaxolol—glaucoma	0.000167	0.000523	CcSEcCtD
Norfloxacin—Rash—Dorzolamide—glaucoma	0.000165	0.000519	CcSEcCtD
Norfloxacin—Dermatitis—Dorzolamide—glaucoma	0.000165	0.000518	CcSEcCtD
Norfloxacin—Rash—Travoprost—glaucoma	0.000165	0.000517	CcSEcCtD
Norfloxacin—Dermatitis—Travoprost—glaucoma	0.000165	0.000516	CcSEcCtD
Norfloxacin—CYP1A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000164	0.00606	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000164	0.00606	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000164	0.00606	CbGpPWpGaD
Norfloxacin—Headache—Dorzolamide—glaucoma	0.000164	0.000515	CcSEcCtD
Norfloxacin—Anorexia—Betaxolol—glaucoma	0.000164	0.000515	CcSEcCtD
Norfloxacin—Vomiting—Brinzolamide—glaucoma	0.000164	0.000514	CcSEcCtD
Norfloxacin—Dizziness—Pilocarpine—glaucoma	0.000164	0.000514	CcSEcCtD
Norfloxacin—Headache—Travoprost—glaucoma	0.000164	0.000513	CcSEcCtD
Norfloxacin—Nausea—Brimonidine—glaucoma	0.000163	0.000512	CcSEcCtD
Norfloxacin—Feeling abnormal—Clonidine—glaucoma	0.000163	0.000512	CcSEcCtD
Norfloxacin—Rash—Brinzolamide—glaucoma	0.000163	0.00051	CcSEcCtD
Norfloxacin—Vision blurred—Timolol—glaucoma	0.000163	0.00051	CcSEcCtD
Norfloxacin—Dermatitis—Brinzolamide—glaucoma	0.000162	0.00051	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Clonidine—glaucoma	0.000162	0.000508	CcSEcCtD
Norfloxacin—Headache—Brinzolamide—glaucoma	0.000162	0.000507	CcSEcCtD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.00016	0.00591	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND2—glaucoma	0.000158	0.00584	CbGpPWpGaD
Norfloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000158	0.00581	CbGpPWpGaD
Norfloxacin—Angioedema—Timolol—glaucoma	0.000158	0.000494	CcSEcCtD
Norfloxacin—Vomiting—Pilocarpine—glaucoma	0.000158	0.000494	CcSEcCtD
Norfloxacin—Urticaria—Clonidine—glaucoma	0.000157	0.000493	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000157	0.000492	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000157	0.00577	CbGpPWpGaD
Norfloxacin—Abdominal pain—Clonidine—glaucoma	0.000157	0.000491	CcSEcCtD
Norfloxacin—Body temperature increased—Clonidine—glaucoma	0.000157	0.000491	CcSEcCtD
Norfloxacin—CYP1A1—Melatonin metabolism and effects—APOE—glaucoma	0.000156	0.00576	CbGpPWpGaD
Norfloxacin—Rash—Pilocarpine—glaucoma	0.000156	0.00049	CcSEcCtD
Norfloxacin—Dermatitis—Pilocarpine—glaucoma	0.000156	0.00049	CcSEcCtD
Norfloxacin—Insomnia—Betaxolol—glaucoma	0.000156	0.000489	CcSEcCtD
Norfloxacin—Nausea—Dorzolamide—glaucoma	0.000156	0.000489	CcSEcCtD
Norfloxacin—Headache—Pilocarpine—glaucoma	0.000155	0.000487	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.000155	0.00572	CbGpPWpGaD
Norfloxacin—Nausea—Travoprost—glaucoma	0.000155	0.000487	CcSEcCtD
Norfloxacin—Vertigo—Timolol—glaucoma	0.000155	0.000486	CcSEcCtD
Norfloxacin—Paraesthesia—Betaxolol—glaucoma	0.000155	0.000485	CcSEcCtD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000154	0.00567	CbGpPWpGaD
Norfloxacin—Dyspnoea—Betaxolol—glaucoma	0.000154	0.000482	CcSEcCtD
Norfloxacin—Nausea—Brinzolamide—glaucoma	0.000153	0.00048	CcSEcCtD
Norfloxacin—Palpitations—Timolol—glaucoma	0.000152	0.000478	CcSEcCtD
Norfloxacin—Dyspepsia—Betaxolol—glaucoma	0.000152	0.000476	CcSEcCtD
Norfloxacin—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000152	0.00559	CbGpPWpGaD
Norfloxacin—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000151	0.00558	CbGpPWpGaD
Norfloxacin—Decreased appetite—Betaxolol—glaucoma	0.00015	0.00047	CcSEcCtD
Norfloxacin—Fatigue—Betaxolol—glaucoma	0.000149	0.000466	CcSEcCtD
Norfloxacin—Constipation—Betaxolol—glaucoma	0.000147	0.000462	CcSEcCtD
Norfloxacin—Nausea—Pilocarpine—glaucoma	0.000147	0.000462	CcSEcCtD
Norfloxacin—Myalgia—Timolol—glaucoma	0.000147	0.000461	CcSEcCtD
Norfloxacin—Chest pain—Timolol—glaucoma	0.000147	0.000461	CcSEcCtD
Norfloxacin—Arthralgia—Timolol—glaucoma	0.000147	0.000461	CcSEcCtD
Norfloxacin—TOP2A—Gastric Cancer Network 2—TP53—glaucoma	0.000147	0.0054	CbGpPWpGaD
Norfloxacin—Anxiety—Timolol—glaucoma	0.000146	0.000459	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000146	0.00538	CbGpPWpGaD
Norfloxacin—Hypersensitivity—Clonidine—glaucoma	0.000146	0.000457	CcSEcCtD
Norfloxacin—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000145	0.00533	CbGpPWpGaD
Norfloxacin—Dry mouth—Timolol—glaucoma	0.000144	0.000451	CcSEcCtD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000143	0.00529	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000142	0.00524	CbGpPWpGaD
Norfloxacin—Asthenia—Clonidine—glaucoma	0.000142	0.000445	CcSEcCtD
Norfloxacin—Feeling abnormal—Betaxolol—glaucoma	0.000142	0.000445	CcSEcCtD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000142	0.00523	CbGpPWpGaD
Norfloxacin—Confusional state—Timolol—glaucoma	0.000142	0.000445	CcSEcCtD
Norfloxacin—CYP2A6—NRF2 pathway—TXN—glaucoma	0.000142	0.00522	CbGpPWpGaD
Norfloxacin—Oedema—Timolol—glaucoma	0.000141	0.000442	CcSEcCtD
Norfloxacin—Anaphylactic shock—Timolol—glaucoma	0.000141	0.000442	CcSEcCtD
Norfloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000141	0.00518	CbGpPWpGaD
Norfloxacin—Pruritus—Clonidine—glaucoma	0.00014	0.000439	CcSEcCtD
Norfloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000139	0.00512	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—FGFR1OP—glaucoma	0.000139	0.00512	CbGpPWpGaD
Norfloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000138	0.00508	CbGpPWpGaD
Norfloxacin—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000137	0.00505	CbGpPWpGaD
Norfloxacin—Urticaria—Betaxolol—glaucoma	0.000137	0.000429	CcSEcCtD
Norfloxacin—Body temperature increased—Betaxolol—glaucoma	0.000136	0.000427	CcSEcCtD
Norfloxacin—Hyperhidrosis—Timolol—glaucoma	0.000136	0.000427	CcSEcCtD
Norfloxacin—Diarrhoea—Clonidine—glaucoma	0.000135	0.000425	CcSEcCtD
Norfloxacin—Anorexia—Timolol—glaucoma	0.000134	0.000421	CcSEcCtD
Norfloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000133	0.00492	CbGpPWpGaD
Norfloxacin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000133	0.0049	CbGpPWpGaD
Norfloxacin—CYP1A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000131	0.00483	CbGpPWpGaD
Norfloxacin—Dizziness—Clonidine—glaucoma	0.000131	0.000411	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle—RAB8A—glaucoma	0.00013	0.00481	CbGpPWpGaD
Norfloxacin—Musculoskeletal discomfort—Timolol—glaucoma	0.000128	0.000402	CcSEcCtD
Norfloxacin—Insomnia—Timolol—glaucoma	0.000127	0.000399	CcSEcCtD
Norfloxacin—Hypersensitivity—Betaxolol—glaucoma	0.000127	0.000398	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—OPTN—glaucoma	0.000127	0.00466	CbGpPWpGaD
Norfloxacin—Paraesthesia—Timolol—glaucoma	0.000126	0.000397	CcSEcCtD
Norfloxacin—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	0.000126	0.00466	CbGpPWpGaD
Norfloxacin—Vomiting—Clonidine—glaucoma	0.000126	0.000395	CcSEcCtD
Norfloxacin—Dyspnoea—Timolol—glaucoma	0.000126	0.000394	CcSEcCtD
Norfloxacin—Somnolence—Timolol—glaucoma	0.000125	0.000393	CcSEcCtD
Norfloxacin—Rash—Clonidine—glaucoma	0.000125	0.000391	CcSEcCtD
Norfloxacin—Dermatitis—Clonidine—glaucoma	0.000125	0.000391	CcSEcCtD
Norfloxacin—Headache—Clonidine—glaucoma	0.000124	0.000389	CcSEcCtD
Norfloxacin—Dyspepsia—Timolol—glaucoma	0.000124	0.000389	CcSEcCtD
Norfloxacin—Asthenia—Betaxolol—glaucoma	0.000124	0.000388	CcSEcCtD
Norfloxacin—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000123	0.00452	CbGpPWpGaD
Norfloxacin—Decreased appetite—Timolol—glaucoma	0.000122	0.000384	CcSEcCtD
Norfloxacin—Pruritus—Betaxolol—glaucoma	0.000122	0.000382	CcSEcCtD
Norfloxacin—Fatigue—Timolol—glaucoma	0.000121	0.000381	CcSEcCtD
Norfloxacin—TOP2A—Circadian rythm related genes—NGFR—glaucoma	0.000118	0.00435	CbGpPWpGaD
Norfloxacin—Diarrhoea—Betaxolol—glaucoma	0.000118	0.00037	CcSEcCtD
Norfloxacin—Nausea—Clonidine—glaucoma	0.000118	0.000369	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000117	0.0043	CbGpPWpGaD
Norfloxacin—Feeling abnormal—Timolol—glaucoma	0.000116	0.000364	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Timolol—glaucoma	0.000115	0.000361	CcSEcCtD
Norfloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000114	0.0042	CbGpPWpGaD
Norfloxacin—Dizziness—Betaxolol—glaucoma	0.000114	0.000357	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle—OPTN—glaucoma	0.000113	0.00417	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—NTRK1—glaucoma	0.000112	0.00413	CbGpPWpGaD
Norfloxacin—Urticaria—Timolol—glaucoma	0.000112	0.000351	CcSEcCtD
Norfloxacin—Body temperature increased—Timolol—glaucoma	0.000111	0.000349	CcSEcCtD
Norfloxacin—Abdominal pain—Timolol—glaucoma	0.000111	0.000349	CcSEcCtD
Norfloxacin—Vomiting—Betaxolol—glaucoma	0.00011	0.000344	CcSEcCtD
Norfloxacin—Rash—Betaxolol—glaucoma	0.000109	0.000341	CcSEcCtD
Norfloxacin—Dermatitis—Betaxolol—glaucoma	0.000109	0.00034	CcSEcCtD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000108	0.00399	CbGpPWpGaD
Norfloxacin—Headache—Betaxolol—glaucoma	0.000108	0.000339	CcSEcCtD
Norfloxacin—CYP1A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000108	0.00397	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000108	0.00397	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000107	0.00394	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—GSTT1—glaucoma	0.000105	0.00388	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000105	0.00386	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000105	0.00386	CbGpPWpGaD
Norfloxacin—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000105	0.00386	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000104	0.00383	CbGpPWpGaD
Norfloxacin—Hypersensitivity—Timolol—glaucoma	0.000104	0.000325	CcSEcCtD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000103	0.0038	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—TGFB2—glaucoma	0.000103	0.0038	CbGpPWpGaD
Norfloxacin—Nausea—Betaxolol—glaucoma	0.000102	0.000321	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000102	0.00377	CbGpPWpGaD
Norfloxacin—Asthenia—Timolol—glaucoma	0.000101	0.000317	CcSEcCtD
Norfloxacin—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	9.97e-05	0.00367	CbGpPWpGaD
Norfloxacin—Pruritus—Timolol—glaucoma	9.96e-05	0.000312	CcSEcCtD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	9.8e-05	0.00361	CbGpPWpGaD
Norfloxacin—CYP2A6—Biological oxidations—GSTT1—glaucoma	9.64e-05	0.00355	CbGpPWpGaD
Norfloxacin—Diarrhoea—Timolol—glaucoma	9.63e-05	0.000302	CcSEcCtD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.57e-05	0.00353	CbGpPWpGaD
Norfloxacin—Dizziness—Timolol—glaucoma	9.31e-05	0.000292	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.15e-05	0.00337	CbGpPWpGaD
Norfloxacin—Vomiting—Timolol—glaucoma	8.95e-05	0.000281	CcSEcCtD
Norfloxacin—Rash—Timolol—glaucoma	8.88e-05	0.000278	CcSEcCtD
Norfloxacin—Dermatitis—Timolol—glaucoma	8.87e-05	0.000278	CcSEcCtD
Norfloxacin—Headache—Timolol—glaucoma	8.82e-05	0.000277	CcSEcCtD
Norfloxacin—TOP2A—Circadian rythm related genes—FAS—glaucoma	8.78e-05	0.00324	CbGpPWpGaD
Norfloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.47e-05	0.00312	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—CYP1B1—glaucoma	8.38e-05	0.00309	CbGpPWpGaD
Norfloxacin—Nausea—Timolol—glaucoma	8.36e-05	0.000262	CcSEcCtD
Norfloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.36e-05	0.00308	CbGpPWpGaD
Norfloxacin—CYP3A7—Metapathway biotransformation—CYP1B1—glaucoma	8.26e-05	0.00305	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—ABCA1—glaucoma	8.18e-05	0.00302	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—glaucoma	8.12e-05	0.00299	CbGpPWpGaD
Norfloxacin—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	8.09e-05	0.00298	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	8.01e-05	0.00295	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase II conjugation—GSTT1—glaucoma	7.83e-05	0.00289	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	7.82e-05	0.00288	CbGpPWpGaD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	7.72e-05	0.00284	CbGpPWpGaD
Norfloxacin—CYP2A6—Biological oxidations—CYP1B1—glaucoma	7.68e-05	0.00283	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—GSTT1—glaucoma	7.6e-05	0.0028	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	7.41e-05	0.00273	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NARFL—glaucoma	7.37e-05	0.00272	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA5A—glaucoma	7.37e-05	0.00272	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.22e-05	0.00266	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—glaucoma	7.19e-05	0.00265	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—GSTT1—glaucoma	7.18e-05	0.00265	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	7.02e-05	0.00259	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	7.02e-05	0.00259	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A1—glaucoma	7e-05	0.00258	CbGpPWpGaD
Norfloxacin—CYP2A6—NRF2 pathway—GSTM1—glaucoma	7e-05	0.00258	CbGpPWpGaD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—PTGS2—glaucoma	6.93e-05	0.00255	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.87e-05	0.00253	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NARFL—glaucoma	6.76e-05	0.00249	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA5A—glaucoma	6.76e-05	0.00249	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—GSTM1—glaucoma	6.7e-05	0.00247	CbGpPWpGaD
Norfloxacin—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	6.61e-05	0.00244	CbGpPWpGaD
Norfloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.54e-05	0.00241	CbGpPWpGaD
Norfloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.45e-05	0.00238	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—glaucoma	6.42e-05	0.00237	CbGpPWpGaD
Norfloxacin—CYP2A6—Biological oxidations—GSTM1—glaucoma	6.14e-05	0.00226	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—CYP1B1—glaucoma	6.06e-05	0.00223	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	5.97e-05	0.0022	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	5.84e-05	0.00215	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—glaucoma	5.81e-05	0.00214	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	5.75e-05	0.00212	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—CYP1B1—glaucoma	5.72e-05	0.00211	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—CYP1B1—glaucoma	5.64e-05	0.00208	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	5.52e-05	0.00203	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.45e-05	0.00201	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.35e-05	0.00197	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA5A—glaucoma	5.33e-05	0.00196	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NARFL—glaucoma	5.33e-05	0.00196	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.3e-05	0.00195	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.29e-05	0.00195	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—glaucoma	5.21e-05	0.00192	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND2—glaucoma	5.19e-05	0.00191	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA5A—glaucoma	5.03e-05	0.00186	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NARFL—glaucoma	5.03e-05	0.00186	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	5e-05	0.00184	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	5e-05	0.00184	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase II conjugation—GSTM1—glaucoma	4.99e-05	0.00184	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—GSTM1—glaucoma	4.84e-05	0.00178	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	4.78e-05	0.00176	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	4.72e-05	0.00174	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2B—glaucoma	4.66e-05	0.00172	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.58e-05	0.00169	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—GSTM1—glaucoma	4.57e-05	0.00169	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.53e-05	0.00167	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	4.51e-05	0.00166	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.47e-05	0.00165	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.47e-05	0.00165	CbGpPWpGaD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.42e-05	0.00163	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.88e-05	0.00143	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.72e-05	0.00137	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.65e-05	0.00134	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA1—glaucoma	3.6e-05	0.00133	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.6e-05	0.00133	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.53e-05	0.0013	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CTSA—glaucoma	3.49e-05	0.00128	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.42e-05	0.00126	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.41e-05	0.00126	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA1—glaucoma	3.3e-05	0.00122	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA2—glaucoma	3.29e-05	0.00121	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—glaucoma	3.29e-05	0.00121	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NARFL—glaucoma	3.21e-05	0.00118	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA5A—glaucoma	3.21e-05	0.00118	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CTSA—glaucoma	3.2e-05	0.00118	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.19e-05	0.00118	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.19e-05	0.00118	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA2—glaucoma	3.02e-05	0.00111	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—glaucoma	2.98e-05	0.0011	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTM1—glaucoma	2.92e-05	0.00108	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	2.88e-05	0.00106	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.82e-05	0.00104	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.78e-05	0.00102	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2A—glaucoma	2.66e-05	0.000982	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—glaucoma	2.64e-05	0.000972	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA1—glaucoma	2.6e-05	0.000959	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CTSA—glaucoma	2.52e-05	0.000929	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NARFL—glaucoma	2.48e-05	0.000913	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA5A—glaucoma	2.48e-05	0.000913	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA1—glaucoma	2.46e-05	0.000906	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CTSA—glaucoma	2.38e-05	0.000877	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA2—glaucoma	2.38e-05	0.000877	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1B—glaucoma	2.36e-05	0.000869	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TXN—glaucoma	2.32e-05	0.000855	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.25e-05	0.00083	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA2—glaucoma	2.25e-05	0.000829	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.22e-05	0.000818	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.2e-05	0.00081	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.2e-05	0.00081	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TXN—glaucoma	2.13e-05	0.000784	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTT1—glaucoma	1.8e-05	0.000663	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TXN—glaucoma	1.68e-05	0.000618	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTT1—glaucoma	1.65e-05	0.000608	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TXN—glaucoma	1.58e-05	0.000584	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA1—glaucoma	1.57e-05	0.000578	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CTSA—glaucoma	1.52e-05	0.000559	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—glaucoma	1.48e-05	0.000546	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.45e-05	0.000533	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA2—glaucoma	1.43e-05	0.000528	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP1B1—glaucoma	1.43e-05	0.000528	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCA1—glaucoma	1.43e-05	0.000528	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.43e-05	0.000528	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.4e-05	0.000516	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.4e-05	0.000516	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCA1—glaucoma	1.31e-05	0.000484	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP1B1—glaucoma	1.31e-05	0.000484	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTT1—glaucoma	1.3e-05	0.000479	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTT1—glaucoma	1.23e-05	0.000453	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA1—glaucoma	1.21e-05	0.000446	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CTSA—glaucoma	1.17e-05	0.000432	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTM1—glaucoma	1.15e-05	0.000422	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA2—glaucoma	1.11e-05	0.000408	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—glaucoma	1.05e-05	0.000387	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1B1—glaucoma	1.04e-05	0.000382	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCA1—glaucoma	1.04e-05	0.000382	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—glaucoma	1.01e-05	0.000373	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TXN—glaucoma	1.01e-05	0.000372	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.9e-06	0.000365	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCA1—glaucoma	9.79e-06	0.000361	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP1B1—glaucoma	9.79e-06	0.000361	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—APOE—glaucoma	9.43e-06	0.000347	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CAV1—glaucoma	9.34e-06	0.000344	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—glaucoma	9.28e-06	0.000342	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.22e-06	0.00034	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.13e-06	0.000337	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APOE—glaucoma	8.64e-06	0.000318	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAV1—glaucoma	8.56e-06	0.000315	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—glaucoma	8.28e-06	0.000305	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—glaucoma	7.83e-06	0.000289	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—glaucoma	7.82e-06	0.000288	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TXN—glaucoma	7.8e-06	0.000287	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—glaucoma	7.32e-06	0.00027	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NOS3—glaucoma	7.06e-06	0.00026	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—glaucoma	6.91e-06	0.000255	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APOE—glaucoma	6.81e-06	0.000251	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAV1—glaucoma	6.75e-06	0.000249	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NOS3—glaucoma	6.47e-06	0.000239	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—glaucoma	6.46e-06	0.000238	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APOE—glaucoma	6.44e-06	0.000237	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAV1—glaucoma	6.38e-06	0.000235	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.31e-06	0.000233	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP1B1—glaucoma	6.24e-06	0.00023	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCA1—glaucoma	6.24e-06	0.00023	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—glaucoma	6.04e-06	0.000223	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—glaucoma	5.92e-06	0.000218	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NOS3—glaucoma	5.1e-06	0.000188	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—glaucoma	4.99e-06	0.000184	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NOS3—glaucoma	4.82e-06	0.000178	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCA1—glaucoma	4.82e-06	0.000177	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1B1—glaucoma	4.82e-06	0.000177	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—glaucoma	4.67e-06	0.000172	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—glaucoma	4.41e-06	0.000163	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTHFR—glaucoma	4.41e-06	0.000162	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APOE—glaucoma	4.1e-06	0.000151	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAV1—glaucoma	4.07e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM1—glaucoma	3.85e-06	0.000142	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—glaucoma	3.4e-06	0.000125	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APOE—glaucoma	3.17e-06	0.000117	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAV1—glaucoma	3.14e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NOS3—glaucoma	3.07e-06	0.000113	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—glaucoma	2.81e-06	0.000104	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NOS3—glaucoma	2.37e-06	8.75e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—glaucoma	2.17e-06	8e-05	CbGpPWpGaD
